Sentinel lymph node biopsy in clinically node-negative Merkel cell carcinoma
SLNB is used to stage clinically node-negative disease and to guide adjuvant therapy decisions.
Sentinel lymph node biopsy (SLNB) is used to stage clinically node-negative disease and to guide adjuvant therapy decisions.
Accurate staging of Merkel cell carcinoma (MCC) can influence subsequent treatment decisions and potentially improve patient outcomes.
Evidence level: Állatkísérletes. Állatmodellben vizsgálták.
Related signals
- Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative, or Not Performed Sentinel Lymph Node Biopsy
- Repurposed pinworm medication shows ‘promise’ as treatment for Merkel cell carcinoma
- Merkel Cell Carcinoma: Epidemiology, Target, and Therapy
- The biology and treatment of Merkel cell carcinoma: current understanding and research priorities
- Avelumab in patients with chemotherapy‑refractory metastatic Merkel cell carcinoma: a multicentre, single‑group, open‑label, phase 2 trial